Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT05804032 · COMPLETED
Trial details
- NCT number
- NCT05804032
- Sponsor
- University of Heidelberg Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2026-01-30
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.